A Next Generation Cancer Treatment - Killing Cancer Tumors From The Inside Out
Update February 7, 2025
We are changing the way cancer is treated.
What is Precision Radionuclide Therapy™
Also known as PRnT™, the treatment uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area, delivering therapeutic radiation from within the tumor. Vivos Inc. has developed a Yttrium-90 based injectable device to treat tumors in animals (IsoPet® Division) and humans (RadioGel® Division, not currently approved by the FDA).
RadioGel®
RadioGel® is a division of Vivos Inc. and holds the patent for a next generation cancer treatment - Precision Radionuclide Therapy (PRnT)™
The future of cancer treatment – the insertion of our radionuclide device directly into the tumor tissue. RadioGel® is currently not approved by the FDA.
